Humana Inc. (NYSE:HUM) Receives $294.32 Consensus Price Target from Brokerages

Shares of Humana Inc. (NYSE:HUM) have received an average rating of “Hold” from the twenty-one brokerages that are presently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have given a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $294.3158.

HUM has been the topic of a number of research analyst reports. Barclays lowered their price objective on shares of Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 25th. Robert W. Baird lowered their price target on Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a report on Thursday, December 11th. Sanford C. Bernstein raised their price objective on shares of Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. KeyCorp reiterated a “sector weight” rating on shares of Humana in a research report on Friday, December 12th. Finally, Wolfe Research lowered their price target on shares of Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a report on Thursday, November 20th.

Institutional Investors Weigh In On Humana

Hedge funds have recently made changes to their positions in the company. Elevation Point Wealth Partners LLC bought a new position in shares of Humana during the 2nd quarter valued at approximately $32,000. Mather Group LLC. purchased a new position in Humana in the third quarter worth about $34,000. AlphaCore Capital LLC purchased a new stake in Humana during the second quarter valued at approximately $39,000. Private Wealth Management Group LLC lifted its stake in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the last quarter. Finally, Larson Financial Group LLC boosted its holdings in shares of Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Up 0.6%

HUM stock opened at $258.78 on Friday. The stock has a market capitalization of $31.12 billion, a P/E ratio of 24.25, a P/E/G ratio of 1.52 and a beta of 0.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. Humana has a 1-year low of $206.87 and a 1-year high of $315.35. The business has a fifty day moving average price of $258.90 and a 200-day moving average price of $259.99.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the company earned $4.16 EPS. Equities analysts forecast that Humana will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s dividend payout ratio (DPR) is presently 33.18%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.